Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging

Details Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging

1997-12-29

2000-02-08

Tsang, Cecilia J.

Drug, bio-affecting and body treating compositions

Radionuclide or intended radionuclide containing; adjuvant...

In an organic compound

424165, 530317, 530330, A61K 5100, A61K 3812

Patent

active

060225238

ABSTRACT:
This invention provides novel radiopharmaceuticals that are radiolabeled cyclic compounds containing carbocyclic or heterocyclic ring systems which act as antagonists of the platelet glycoprotein IIb/IIIa complex; to methods of using said radiopharmaceuticals as imaging agents for the diagnosis of arterial and venous thrombi; to novel reagents for the preparation of said radiopharmaceuticals; and to kits comprising said reagents.

REFERENCES:
patent: 4444690 (1984-04-01), Fritzberg et al.
patent: 4517686 (1985-05-01), Ruoslahti et al.
patent: 4578079 (1986-03-01), Ruoslahti et al.
patent: 4589881 (1986-05-01), Pierschbacher et al.
patent: 4614517 (1986-09-01), Ruoslahti et al.
patent: 4661111 (1987-04-01), Rouslahti et al.
patent: 4670545 (1987-06-01), Fritzberg et al.
patent: 4673562 (1987-06-01), Davison et al.
patent: 4746505 (1988-05-01), Jones et al.
patent: 4792525 (1988-12-01), Rouslahti et al.
patent: 4861869 (1989-08-01), Nicolotti et al.
patent: 4879237 (1989-11-01), Rouslahti et al.
patent: 4883862 (1989-11-01), Chervu et al.
patent: 4897255 (1990-01-01), Fritzberg et al.
patent: 4925650 (1990-05-01), Nosco et al.
patent: 4952562 (1990-08-01), Klein et al.
patent: 4963688 (1990-10-01), Bodor
patent: 4965392 (1990-10-01), Fritzbeeg et al.
patent: 4988621 (1991-01-01), Ruoslahti et al.
patent: 5023233 (1991-06-01), Nutt et al.
patent: 5026913 (1991-06-01), McBride et al.
patent: 5037631 (1991-08-01), Nosco
patent: 5041380 (1991-08-01), Rouslahti et al.
patent: 5053503 (1991-10-01), Dean et al.
patent: 5080884 (1992-01-01), McBride et al.
patent: 5082930 (1992-01-01), Nicolotti et al.
patent: 5095111 (1992-03-01), Lever et al.
patent: 5120829 (1992-06-01), Pierschbacher et al.
patent: 5144043 (1992-09-01), Dean et al.
patent: 5175256 (1992-12-01), Kasina et al.
patent: 5175343 (1992-12-01), Fritzberg et al.
patent: 5180816 (1993-01-01), Dean
patent: 5192380 (1993-03-01), Hanada et al.
patent: 5192745 (1993-03-01), Krstenansky et al.
patent: 5192746 (1993-03-01), Lobl et al.
patent: 5218128 (1993-06-01), Dean et al.
patent: 5225180 (1993-07-01), Dean et al.
patent: 5236898 (1993-08-01), Krstenansky et al.
patent: 5250666 (1993-10-01), Gustavson et al.
patent: 5276147 (1994-01-01), Thornback et al.
patent: 5279811 (1994-01-01), Bergstein et al.
patent: 5279812 (1994-01-01), Krstenansky et al.
patent: 5635477 (1997-06-01), Degrado et al.
patent: 5879657 (1999-03-01), Degrado et al.

Affiliated with

Also associated with

Rating

Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1678460